| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |